The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000778381
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
4/05/2026
Date registered
Help: Date registered
29/06/2026
Date last updated
Help: Date last updated
29/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
29/06/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Split Face Comparison of Topical Arnica Montana for Post Rhinoplasty Ecchymosis and Oedema
Scientific title
Effect of Topical Arnica Cream on Postoperative Oedema and Ecchymosis After Septorhinoplasty: A Prospective, Randomised, Split-Face, Blinded Study
Additional trial identifiers [1] 317194 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
rhinoplasty 341773 0
Condition category
Condition code
Surgery 337856 337856 0 0
Other surgery

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants applied 1g or two fingertips of Arnica Montana 20mg/g (Martin & Pleasance Arnica Cream) cream twice daily to the assigned hemiface excluding the columella incision for 10 days postoperatively.
Participant self reported adherence.
Intervention code [1] 333960 0
Treatment: Drugs
Description of the comparator or control
Control group was hemi face that did not apply Arnica and there was no control cream placed.
Control group
Active

Outcomes
Primary outcome [1] 345306 0
postoperative periorbital ecchymosis extent
Timepoint [1] 345306 0
Post operative day 1,4,7
Primary outcome [2] 345607 0
Colour of ecchymosis
Timepoint [2] 345607 0
Post operative day 1,4,7
Primary outcome [3] 345608 0
Post operative oedema
Timepoint [3] 345608 0
Day 1,4,7 post operative
Secondary outcome [1] 461258 0
Commission on Illumination L (Lightness), A (red/Green axis), B (yellow/blue axis) (CIELAB) colour difference (delta sign) between arnica-treated and control hemifaces
Timepoint [1] 461258 0
Post Operative Day 1,4,7

Eligibility
Key inclusion criteria
Patients were recruited between August 2022 and November 2023 from the Otolaryngology outpatient department at the Royal Brisbane and Women’s Hospital (RBWH), Brisbane, Australia. Eligible patients undergoing septorhinoplasty were identified from a prospective surgical waiting list database and invited to participate during pre-operative appointments. Patients received no financial compensation for participation
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Exclusion criteria included: coagulopathy or anticoagulant use; systemic disease affecting oedema or wound healing; pregnancy or breastfeeding; hypersensitivity to Arnica or excipients; inability to comply with specified treatment instructions or photographic documentation, and insufficient English proficiency for consent and instructions

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
central randomisation
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computer-generated sequence to balance distribution
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Other design features
Phase
Phase 1
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 29468 0
Royal Brisbane & Womens Hospital - Herston
Recruitment postcode(s) [1] 45786 0
4029 - Herston

Funding & Sponsors
Funding source category [1] 321776 0
Self funded/Unfunded
Name [1] 321776 0
Cameron Grigg - Royal Brisbane and Women's hospital
Country [1] 321776 0
Australia
Primary sponsor type
Individual
Name
Cameron Grigg - Royal Brisbane and Women's hospital
Address
Country
Australia
Secondary sponsor category [1] 324617 0
None
Name [1] 324617 0
Address [1] 324617 0
Country [1] 324617 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320320 0
Metro North Health Human Research Ethics Committee
Ethics committee address [1] 320320 0
Ethics committee country [1] 320320 0
Australia
Date submitted for ethics approval [1] 320320 0
24/03/2022
Approval date [1] 320320 0
26/04/2022
Ethics approval number [1] 320320 0
HREC/2021/QRBW/80888

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150078 0
Dr Cameron Grigg
Address 150078 0
RBWH 288 Herston Rd, Herston QLD 4006
Country 150078 0
Australia
Phone 150078 0
+61 07 36468111
Fax 150078 0
Email 150078 0
Contact person for public queries
Name 150079 0
Cameron Grigg
Address 150079 0
RBWH 288 Herston Rd, Herston QLD 4006
Country 150079 0
Australia
Phone 150079 0
+61 07 36468111
Fax 150079 0
Email 150079 0
Contact person for scientific queries
Name 150080 0
Cameron Grigg
Address 150080 0
RBWH 288 Herston Rd, Herston QLD 4006
Country 150080 0
Australia
Phone 150080 0
+61 07 36468111
Fax 150080 0
Email 150080 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.